Flexeril and Lidex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Lidex (fluocinonide). Common drug interactions include fatigue among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Lidex. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Lidex?

Lidex has active ingredients of fluocinonide. eHealthMe is studying from 1,039 Lidex users. Check the latest studies of Lidex.



On Jul, 15, 2026

38 people who take Flexeril and Lidex together, and have interactions are studied.

Flexeril and Lidex drug interactions.

What are the common drug interactions of Flexeril and Lidex, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Fibromyalgia (a long-term condition which causes pain all over the body)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  5. Gout (uric acid crystals building up in the body)
  6. Heart rate irregular
  7. Hospitalisation
  8. Hyperaesthesia
  9. Hypercholesterolaemia (high levels of cholesterol in the blood)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Back disorder
  4. Headache (pain in head)
  5. Migraine (headache)
  6. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  7. Pancreatitis (inflammation of pancreas)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Aphasia (damage to the parts of the brain that control language)
  10. Balance disorder

What are the common drug interactions of Flexeril and Lidex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Appendicitis (inflammation of the appendix)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

30-39:

  1. Malaise (a feeling of general discomfort or uneasiness)

40-49:

  1. Chronic kidney disease
  2. Dehydration (dryness resulting from the removal of water)
  3. Gastric ulcer perforation (stomach hole due to ulcer)
  4. Mobility decreased (ability to move is reduced)
  5. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Renal failure (kidney dysfunction)
  7. Spinal pain (pain in spine)

50-59:

  1. Death
  2. Drug dependence
  3. Emotional distress
  4. Fall
  5. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  6. Hyperaesthesia
  7. Intervertebral disc disorder (spinal disc disorder)
  8. Lumbar radiculopathy (radicular pain in the low back and legs)
  9. Muscular weakness (muscle weakness)
  10. Peroneal nerve palsy

60+:

  1. Pain in extremity
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Stress
  7. Back disorder
  8. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  9. Migraine (headache)
  10. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

  1. Pain: 19 people, 50.00%
  2. Constipation: 7 people, 18.42%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 18.42%
  4. Migraine (headache): 7 people, 18.42%
  5. Nausea (feeling of having an urge to vomit): 7 people, 18.42%
  6. High Blood Pressure: 6 people, 15.79%
  7. General Physical Health Deterioration (weak health status): 4 people, 10.53%
  8. Hypersensitivity: 4 people, 10.53%
  9. Nausea And Vomiting: 4 people, 10.53%
  10. Blood Pressure Abnormal: 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Lidex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Lidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and fluocinonide (the active ingredients of Flexeril and Lidex, respectively), and Flexeril and Lidex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: